Indeed, in a small cohort study on chronic hepatitis B patients, core mutation I97L appeared to be useful in predicting a persistent low level of HBV DNA, normal ALT, and HBsAg clearance [95]. This evidence concerns the gene GPT and chronic hepatitis B virus infection.